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Introduction: Despite the success of current vaccines, there is a clear need for the 
development of vaccines with novel approaches against resistant pathogens such as 
HIV, HCV and TB (tuberculosis). Vaccine improvements may include the addition 
of new adjuvants, which are able to induce higher immune responses. SWCNTs 
display characteristics that are potentially useful in their development as scaffolds 
for vaccine compositions. These features include stability in vivo, multivalency and 
lack of intrinsic immunogenicity. In addition, the particulate nature of carbon 
nanotubes and their rapid entry into antigen-presenting cells, such as dendritic cells, 
make them especially useful carriers of antigens. Recent studies have demonstrated 
that carbon nanotube-based vaccines are promising in both infectious disease 
settings and cancer. In this study, we have developed optimized DSPE-PEG-
SWCNTs for optimized HbS antigen loading and immune responses.   
Methods and Results: Firstly, noncovalent functionalization of SWCNTs with 
DSPE-PEG5000-COOH and DSPE-PEG2000-COOH were performed to improve 
aqueous dispersibility, biocompatibility, immune stimulatory and antigen loading. 
HbS antigen loading was then optimized through D-optimal design. DSPE-PEG-
SWNT type was a categorical factor and HbS antigen concentration, incubation 
time, temperature and stirring speed were numerical independent factors. Optimized 
solutions with LE% of 53% were achieved at 300 µg/ml of HbS antigen 
concentration with DSPE-PEG-2000-COOH. 
Conclusions: Numerous approaches are in process in vaccine development 
including the use of nanocarriers with special features such as multivalency, 
stability, and a likelihood of internalization into antigen presenting cells. The use of 
carbon nanotubes is just beginning and a better understanding of the specifications 
that control this process, are required to optimize their future use in this field. 
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